An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
NCT00002008 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To determine the safety, immunogenicity, biological activity, ad pharmacokinetics of sargramostim ( recombinant granulocyte-macrophage colony-stimulating factor; GM-CSF ) human granulocyte-macrophage colony-stimulating factor ( GM-CSF ), given by subcutaneous ( SC ) injection to patients with leukopenia in association with HIV infection.
Conditions
- HIV Infections
- Cytopenias
Interventions
- DRUG
-
Sargramostim
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
NCT00002255 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
NCT00002281 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
NCT00000850 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002005 ·Status: COMPLETED ·Phase: NA
-
A Study of Stem Cells and Filgrastim
NCT00001071 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV
NCT06557785 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
NCT00000694 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002004 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of SAR441236
NCT03705169 ·Status: TERMINATED ·Phase: PHASE1
-
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients
NCT02500849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
NCT02225665 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
NCT01044654 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells
NCT03856996 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia
NCT00002258 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects
NCT01252641 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
NCT00842634 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV
NCT05471076 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
NCT00764946 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients
NCT02388594 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant
NCT00001019 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T
NCT04201782 ·Status: TERMINATED
-
Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
NCT00272493 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy
NCT04561258 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine
NCT00001112 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
NCT00000976 ·Status: COMPLETED ·Phase: PHASE1